Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Merck & Co Inc. (MRK)

Merck Closes Acquisition Of Terns Pharmaceuticals 5/5/2026 8:49:52 AM

Amended: Merck Slips To Q1 Loss On Acquisition Charges, Revises Annual Outlook; Stock Up 4/30/2026 7:22:12 AM

Merck Q1 GAAP Loss Per Share $1.72; Non-GAAP Loss Per Share $1.28 4/30/2026 6:34:47 AM

Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharma 4/24/2026 6:48:16 AM

Merck Partners Google Cloud In Up To $1 Bln AI Transformation Deal 4/22/2026 8:44:27 AM

Merck And Google Cloud Launch $1 Bln AI Partnership To Transform Enterprise Operations 4/22/2026 8:10:39 AM

Merck: FDA Grants Priority Review For SBLAs For KEYTRUDA, KEYTRUDA QLEX, Each With Padcev 4/20/2026 7:13:10 AM

Merck: FDA Grants Priority Review For Keytruda For The Treatment Of Bladder Cancer Therapies 4/20/2026 6:59:25 AM

Daiichi Sankyo: FDA Grants Priority Review For Ifinatamab Deruxtecan 4/13/2026 7:28:02 AM

Daiichi Sankyo, Merck: FDA Grants Priority Review For Ifinatamab Deruxtecan For Treatment Of Adult Patients With ES-SCLC 4/13/2026 7:06:18 AM

GLP-1 Drugs Move Up The Leaderboard As Twin Epidemics Continue To Balloon 4/13/2026 4:30:46 AM

Novel Drugs Approved By The FDA In 2025 4/10/2026 7:58:33 AM

Merck Launches Tender Offer To Acquire Terns Pharmaceuticals 4/7/2026 9:18:00 AM

Merck Launches Tender Offer To Acquire All Outstanding Shares Of Terns Pharmaceuticals 4/7/2026 9:05:22 AM

Merck Begins Phase 2b/3 Trial Of MK-8748 For The Treatment Of Neovascular Age-Related Macular Degeneration 4/2/2026 6:54:05 AM

Merck's WINREVAIR Phase 2 CADENCE Trial Shows Positive Proof-of-Concept In Pulmonary Hypertension 3/29/2026 12:38:30 PM

Weekly Buzz: CORT Wins FDA Nod In Cancer; MRK Acquires TERN; INSM Meets Trial Goals But VALN Misses 3/27/2026 9:42:17 AM

Agilent Gets FDA Approval For PD-L1 IHC 22C3 PharmDx In Esophageal And GEJ Carcinoma 3/26/2026 8:06:59 AM

Terns Pharmaceuticals Stock Gains 5% Over Acquisition Deal With Merck 3/25/2026 9:58:21 AM

Merck To Acquire Terns For $53.00/shr 3/25/2026 7:06:45 AM

- 1
- 2
- Next »

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap